“BI, Phase IIa open-label study to evaluate the safety, efficacy, pharmacokinetics and pharmacodynamics of BI 764122 in patients with Crohn’s Disease, who were previously treated with anti-TNF therapy”, Comac Medical Ltd. Study-Protocol No. I6T-MC-AMAN.